Dr. Mohamed Shehata


Consultant Interventional Cardiology

Work Experience

  • Dr Mohamed Shehata has over 18 years of experience working as an Interventional Cardiologist. Prior to joining Zulekha Hospital Dubai he has been associated with Burjeel Specialty Hospital, Sharjah, and Thumbay & Saudi German Hospital as Consultant Interventional Cardiologist.
  • Dr. Shehata is a fellow of European Society of Cardiology (ESC) and Society of Cardiovascular Angiography & Intervention (SCAI, USA). He has also served as Associate Professor of Cardiology in Ain Shams University (Cairo, Egypt).

Languages Spoken

  • English
  • Arabic

Special Interests:-

  • Emergency cardiac procedure (pericardial tapping, temporary pacing)
  • Emergency (primary) coronary intervention.
  • Elective coronary intervention.
  • Coronary Imaging (IVUS- OCT)
  • Coronary Physiologic assessment (FFR)
  • Noninvasive cardiac procedures (Echocardiography- TMT- Holter)

Research / Publications

  • Shehata M. Impact of trimetazidine on incidence of myocardial injury and contrast-induced nephropathy in diabetic patients with renal dysfunction undergoing elective percutaneous coronary intervention. Am J Cardiol. 2014 Aug 1;114(3):389-94. doi: 10.1016/j.amjcard.2014.04.052. Epub 2014 May 16.
  • Shehata M, Hamza M. Impact of High Loading Dose of Atorvastatin in Diabetic Patients with Renal Dysfunction Undergoing Elective Percutaneous Coronary Intervention: A Randomized Controlled Trial. Cardiovasc Ther. 2015 Feb 9. doi: 10.1111/1755-5922.12108.
  • Shehata M. Value of Two-Dimensional Strain Imaging in Prediction of Myocardial Function Recovery after Percutaneous Revascularization of Infarct-Related Artery. Echocardiography. 2014 Nov 24. doi: 10.1111/echo.12704.
  • Shehata M. Relation between ischemic threshold measured during dobutamine stress echocardiography and coronary angiographic features. Kardiol Pol. 2014 May 20. doi: 10.5603/KP.a2014.0111.
  • Mohamed Shehata. Late Re-assessment of Myocardial Viability After Acute Myocardial Infarction: Is There Still a Chance?per Title. Experimental & Clinical Cardiology. Volume 20, Issue 1, 2014. (http://www.cardiologyacademicpress.com/?p=19736/Mohamed Shehata/Exp Clin Cardiol Vol 20 Issue1 pages 1062-1092/ 2014).
  • Shehata M. Atropine first is safer than conventional atropine administration in older people undergoing dobutamine stress echocardiography. Ther Adv Cardiovasc Dis. 2014 Oct;8(5):176-84. doi: 10.1177/1753944714538112. Epub 2014 Jun 5.
  • Shehata M. Cardioprotective effects of oral nicorandil use in diabetic patients undergoing elective percutaneous coronary intervention. J Interv Cardiol. 2014 Oct;27(5):472-81. doi: 10.1111/joic.12142. Epub 2014 Aug 30.
  • Shehata M, Samir A, Dardiri M. Prognostic impact of intensive statin therapy on N-terminal pro-BNP level in non-ST-segment elevation acute myocardial infarction patients. J Interv Cardiol. 2017 Aug 15. doi: 10.1111/joic.12427.
  • Hashad IM, Hossni NM, Abdel Rahman MF, Shehata M, Shaban G, Gad MZ. C(-260)T Polymorphism in CD14 Receptor Gene of Egyptians with Acute Myocardial Infarction. Curr Pharm Biotechnol. 2018;19(4):336-342. doi: 10.2174/1389201019666180605125803.
  • Khalil A, Shehata M, Abdeltawab A, Onsy A. Red blood cell distribution width and coronary artery disease severity in diabetic patients. Future Cardiol. 2019 Sep;15(5):355-366. doi: 10.2217/fca-2018-0066.

Other Doctors